Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02318511 · ClinicalTrials.gov registry record · NA
An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis
A NA study, sponsored by NuTech Medical.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT02318511 is a NA study that has completed, run by NuTech Medical. The registered enrollment target is 200 participants.
The verdict
NCT02318511, a NA study, has completed, sponsored by NuTech Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA) injection - with commonly used injection material and 3) Saline. After treatment, patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.
Interventions
- PROCEDURE Knee injection
- OTHER ReNu amniotic allograft
- DEVICE placebo saline
- DEVICE Hyaluronic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02318511
The ClinicalTrials.gov registry entry for NCT02318511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuTech Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Knee injection is the first listed.
NCT02318511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02318511 about?
NCT02318511 is a clinical study titled "An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis". This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA) injection - with commonl...
What is the current status of trial NCT02318511?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-06. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02318511?
The interventions under investigation include: Knee injection (PROCEDURE), ReNu amniotic allograft (OTHER), placebo saline (DEVICE), Hyaluronic Acid (DEVICE).
Who is sponsoring clinical trial NCT02318511?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.